GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:GHC • IT0005345233

5.485 EUR
-0.03 (-0.63%)
Last: Feb 10, 2026, 12:29 PM
Fundamental Rating

4

Overall GHC gets a fundamental rating of 4 out of 10. We evaluated GHC against 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of GHC get a neutral evaluation. Nothing too spectacular is happening here. GHC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year GHC was profitable.
  • GHC had a positive operating cash flow in the past year.
  • In the past 5 years GHC has always been profitable.
  • Each year in the past 5 years GHC had a positive operating cash flow.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • With a decent Return On Assets value of 3.66%, GHC is doing good in the industry, outperforming 62.07% of the companies in the same industry.
  • GHC has a Return On Equity of 9.57%. This is comparable to the rest of the industry: GHC outperforms 51.72% of its industry peers.
  • With a decent Return On Invested Capital value of 6.52%, GHC is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GHC is below the industry average of 6.49%.
  • The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROIC 6.52%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • GHC has a better Profit Margin (4.62%) than 75.86% of its industry peers.
  • GHC's Profit Margin has declined in the last couple of years.
  • GHC's Operating Margin of 9.37% is fine compared to the rest of the industry. GHC outperforms 79.31% of its industry peers.
  • In the last couple of years the Operating Margin of GHC has declined.
  • The Gross Margin of GHC (44.90%) is better than 65.52% of its industry peers.
  • GHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GHC is destroying value.
  • The number of shares outstanding for GHC remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for GHC has been increased compared to 5 years ago.
  • The debt/assets ratio for GHC has been reduced compared to a year ago.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • GHC has an Altman-Z score of 1.97. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GHC's Altman-Z score of 1.97 is in line compared to the rest of the industry. GHC outperforms 55.17% of its industry peers.
  • GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
  • GHC's Debt to FCF ratio of 70.49 is on the low side compared to the rest of the industry. GHC is outperformed by 68.97% of its industry peers.
  • GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
  • GHC's Debt to Equity ratio of 0.67 is fine compared to the rest of the industry. GHC outperforms 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Altman-Z 1.97
ROIC/WACC0.99
WACC6.58%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
  • GHC's Current ratio of 1.16 is in line compared to the rest of the industry. GHC outperforms 58.62% of its industry peers.
  • GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GHC's Quick ratio of 1.12 is fine compared to the rest of the industry. GHC outperforms 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.12
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

  • The earnings per share for GHC have decreased strongly by -12.11% in the last year.
  • GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
  • Looking at the last year, GHC shows a quite strong growth in Revenue. The Revenue has grown by 10.44% in the last year.
  • The Revenue has been growing by 18.92% on average over the past years. This is quite good.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.47% on average over the next years.
  • GHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.24, which indicates a correct valuation of GHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of GHC indicates a somewhat cheap valuation: GHC is cheaper than 72.41% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.06, GHC is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 16.97, which indicates a correct valuation of GHC.
  • The rest of the industry has a similar Price/Forward Earnings ratio as GHC.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, GHC is valued a bit cheaper.
Industry RankSector Rank
PE 15.24
Fwd PE 16.97
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 79.31% of the companies in the same industry are more expensive than GHC, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 152.32
EV/EBITDA 7.55
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.42
PEG (5Y)1.73
EPS Next 2Y5.05%
EPS Next 3Y6.47%

2

5. Dividend

5.1 Amount

  • GHC has a Yearly Dividend Yield of 1.57%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.61, GHC has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, GHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.57%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

GAROFALO HEALTH CARE SPA

BIT:GHC (2/10/2026, 12:29:21 PM)

5.485

-0.03 (-0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap494.75M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (22.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.24
Fwd PE 16.97
P/S 0.72
P/FCF 152.32
P/OCF 17.71
P/B 1.48
P/tB N/A
EV/EBITDA 7.55
EPS(TTM)0.36
EY6.56%
EPS(NY)0.32
Fwd EY5.89%
FCF(TTM)0.04
FCFY0.66%
OCF(TTM)0.31
OCFY5.65%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.42
PEG (5Y)1.73
Graham Number5.47
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROCE 9.13%
ROIC 6.52%
ROICexc 6.77%
ROICexgc 14.86%
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
FCFM 0.47%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Debt/EBITDA 2.47
Cap/Depr 94.13%
Cap/Sales 3.57%
Interest Coverage 6.62
Cash Conversion 30.7%
Profit Quality 10.18%
Current Ratio 1.16
Quick Ratio 1.12
Altman-Z 1.97
F-Score5
WACC6.58%
ROIC/WACC0.99
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%

GAROFALO HEALTH CARE SPA / GHC.MI FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.


How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.


What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.